BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Russel MG, Stockbrügger RW. Epidemiology of inflammatory bowel disease: an update. Scand J Gastroenterol. 1996;31:417-427. [PMID: 8734336 DOI: 10.3109/00365529609006759] [Cited by in Crossref: 108] [Cited by in F6Publishing: 98] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Clemett D, Markham A. Prolonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease. Drugs 2000;59:929-56. [PMID: 10804042 DOI: 10.2165/00003495-200059040-00016] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 2.0] [Reference Citation Analysis]
2 Bernstein CN, Nabalamba A. Hospitalization, surgery, and readmission rates of IBD in Canada: a population-based study. Am J Gastroenterol 2006;101:110-8. [PMID: 16405542 DOI: 10.1111/j.1572-0241.2006.00330.x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 99] [Article Influence: 6.6] [Reference Citation Analysis]
3 Odes S. How expensive is inflammatory bowel disease? A critical analysis. World J Gastroenterol 2008; 14(43): 6641-6647 [PMID: 19034966 DOI: 10.3748/wjg.14.6641] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
4 Gutierrez LS. The role of thrombospondin 1 on intestinal inflammation and carcinogenesis. Biomark Insights 2008;3:171-8. [PMID: 19079771 DOI: 10.4137/bmi.s630] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kim SJ, Kim KW, Kim DS, Kim MC, Jeon YD, Kim SG, Jung HJ, Jang HJ, Lee BC, Chung WS, Hong SH, Chung SH, Um JY. The protective effect of Cassia obtusifolia on DSS-induced colitis. Am J Chin Med 2011;39:565-77. [PMID: 21598422 DOI: 10.1142/S0192415X11009032] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
6 Elia PP, Fogaça HS, Barros RG, Zaltman C, Elia CS. [Descriptive analysis of the social, clinical, laboratorial and anthropometric profiles of inflammatory bowel disease inwards patients from the “Clementino Fraga Filho” University Hospital, Rio de Janeiro, RJ, Brazil]. Arq Gastroenterol. 2007;44:332-339. [PMID: 18317653 DOI: 10.1590/s0004-28032007000400010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
7 Kugathasan S, Amre D. Inflammatory bowel disease--environmental modification and genetic determinants. Pediatr Clin North Am. 2006;53:727-749. [PMID: 16873002 DOI: 10.1016/j.pcl.2006.05.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
8 Metge CJ, Blanchard JF, Peterson S, Bernstein CN. Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study. Am J Gastroenterol 2001;96:3348-55. [PMID: 11774948 DOI: 10.1111/j.1572-0241.2001.05255.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.1] [Reference Citation Analysis]
9 Gisbert JP, Chaparro M. Systematic review with meta-analysis: inflammatory bowel disease in the elderly. Aliment Pharmacol Ther 2014;39:459-77. [PMID: 24405149 DOI: 10.1111/apt.12616] [Cited by in Crossref: 97] [Cited by in F6Publishing: 82] [Article Influence: 12.1] [Reference Citation Analysis]
10 Zak S, Treven J, Nash N, Gutierrez LS. Lack of thrombospondin-1 increases angiogenesis in a model of chronic inflammatory bowel disease. Int J Colorectal Dis 2008;23:297-304. [PMID: 18043928 DOI: 10.1007/s00384-007-0397-5] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
11 Odes S, Vardi H, Friger M, Wolters F, Russel MG, Riis L, Munkholm P, Politi P, Tsianos E, Clofent J, Vermeire S, Monteiro E, Mouzas I, Fornaciari G, Sijbrandij J, Limonard C, Van Zeijl G, O'morain C, Moum B, Vatn M, Stockbrugger R; European Collaborative Study on Inflammatory Bowel Disease. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation. Gastroenterology. 2006;131:719-728. [PMID: 16952541 DOI: 10.1053/j.gastro.2006.05.052] [Cited by in Crossref: 161] [Cited by in F6Publishing: 146] [Article Influence: 10.1] [Reference Citation Analysis]
12 Xu L, Yang ZL, Li P, Zhou YQ. Modulating effect of Hesperidin on experimental murine colitis induced by dextran sulfate sodium. Phytomedicine. 2009;16:989-995. [PMID: 19386481 DOI: 10.1016/j.phymed.2009.02.021] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]
13 Viscido A, Bagnardi V, Sturniolo G, Annese V, Frieri G, D'arienzo A, Papi C, Riegler G, Corrao G, Caprilli R. Survival and causes of death in Italian patients with ulcerative colitis A GISC nation-wide study. Digestive and Liver Disease 2001;33:686-92. [DOI: 10.1016/s1590-8658(01)80046-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
14 Newby EA, Croft NM, Green M, Hassan K, Heuschkel RB, Jenkins H, Casson DH. Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases. J Pediatr Gastroenterol Nutr. 2008;46:539-545. [PMID: 18493209 DOI: 10.1097/mpg.0b013e3181596efd] [Cited by in Crossref: 38] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
15 Singh UP, Singh NP, Busbee B, Guan H, Singh B, Price RL, Taub DD, Mishra MK, Nagarkatti M, Nagarkatti PS. Alternative medicines as emerging therapies for inflammatory bowel diseases. Int Rev Immunol. 2012;31:66-84. [PMID: 22251008 DOI: 10.3109/08830185.2011.642909] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
16 Yang GY, Taboada S, Liao J. Inflammatory bowel disease: a model of chronic inflammation-induced cancer. Methods Mol Biol. 2009;511:193-233. [PMID: 19347299 DOI: 10.1007/978-1-59745-447-6_9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
17 Frisch M, Johansen C, Mellemkjaer L, Engels EA, Gridley G, Biggar RJ, Olsen JH. Appendectomy and subsequent risk of inflammatory bowel diseases. Surgery. 2001;130:36-43. [PMID: 11436010 DOI: 10.1067/msy.2001.115362] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 2.2] [Reference Citation Analysis]
18 Siddique I, Alazmi W, Al-ali J, Longenecker JC, Al-fadli A, Hasan F, Memon A. Demography and clinical course of ulcerative colitis in Arabs – a study based on the Montreal classification. Scandinavian Journal of Gastroenterology 2014;49:1432-40. [DOI: 10.3109/00365521.2014.966318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Kugathasan S, Judd RH, Hoffmann RG, Heikenen J, Telega G, Khan F, Weisdorf-Schindele S, San Pablo W Jr, Perrault J, Park R, Yaffe M, Brown C, Rivera-Bennett MT, Halabi I, Martinez A, Blank E, Werlin SL, Rudolph CD, Binion DG; Wisconsin Pediatric Inflammatory Bowel Disease Alliance. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003;143:525-531. [PMID: 14571234 DOI: 10.1067/s0022-3476(03)00444-x] [Cited by in Crossref: 415] [Cited by in F6Publishing: 124] [Article Influence: 21.8] [Reference Citation Analysis]
20 Maharshak N, Arbel Y, Bornstein NM, Gal-Oz A, Gur AY, Shapira I, Rogowski O, Berliner S, Halpern Z, Dotan I. Inflammatory bowel disease is not associated with increased intimal media thickening. Am J Gastroenterol 2007;102:1050-5. [PMID: 17313498 DOI: 10.1111/j.1572-0241.2007.01086.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
21 Bodger K. Cost of illness of Crohn's disease. Pharmacoeconomics 2002;20:639-52. [PMID: 12162753 DOI: 10.2165/00019053-200220100-00001] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 3.0] [Reference Citation Analysis]
22 Hanauer SB, Cohen RD, Becker RV, Larson LR, Vreeland MG. Advances in the management of Crohn's disease: economic and clinical potential of infliximab. Clinical Therapeutics 1998;20:1009-28. [DOI: 10.1016/s0149-2918(98)80082-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
23 Wolters FL, Russel MG, Stockbrügger RW. Systematic review: has disease outcome in Crohn’s disease changed during the last four decades? Aliment Pharmacol Ther. 2004;20:483-496. [PMID: 15339320 DOI: 10.1111/j.1365-2036.2004.02123.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 4.4] [Reference Citation Analysis]
24 Amre DK, Seidman EG. DNA variants in cytokine and NOD2 genes, exposures to infections and risk for Crohn's disease. Paediatr Perinat Epidemiol 2003;17:302-12. [DOI: 10.1046/j.1365-3016.2003.00501.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
25 Katz S, Surawicz C, Pardi DS. Management of the Elderly Patients with Inflammatory Bowel Disease: Practical Considerations. Inflammatory Bowel Diseases 2013;19:2257-72. [DOI: 10.1097/mib.0b013e31828c8536] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 2.1] [Reference Citation Analysis]
26 Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am. 1999;28:255-281, vii. [PMID: 10372268 DOI: 10.1016/s0889-8553(05)70056-x] [Cited by in Crossref: 197] [Cited by in F6Publishing: 58] [Article Influence: 8.6] [Reference Citation Analysis]
27 Meucci G, Vecchi M, Astegiano M, Beretta L, Cesari P, Dizioli P, Ferraris L, Panelli MR, Prada A, Sostegni R. The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol. 2000;95:469-473. [PMID: 10685752 DOI: 10.1111/j.1572-0241.2000.t01-1-01770.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 77] [Article Influence: 3.9] [Reference Citation Analysis]
28 Tam YH, Lee KH, Chan KW, Sihoe JDY, Cheung ST, Mou JWC. Colonoscopy in Hong Kong Chinese children. World J Gastroenterol 2010; 16(9): 1119-1122 [PMID: 20205284 DOI: 10.3748/wjg.v16.i9.1119] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
29 Fujimoto T, Kato J, Nasu J, Kuriyama M, Okada H, Yamamoto H, Mizuno M, Shiratori Y. Change of clinical characteristics of ulcerative colitis in Japan: analysis of 844 hospital-based patients from 1981 to 2000. Eur J Gastroenterol Hepatol. 2007;19:229-235. [PMID: 17301650 DOI: 10.1097/meg.0b013e3280110fb9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
30 van der Eijk I, Stockbrügger R, Russel M. Influence of quality of care on quality of life in inflammatory bowel disease (IBD): literature review and studies planned. European Journal of Internal Medicine 2000;11:228-34. [DOI: 10.1016/s0953-6205(00)00095-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
31 Tzen CY, Wu TY, Tzen CY. Detection of mycobacteria in Crohn‘s disease by a broad spectrum polymerase chain reaction. J Formos Med Assoc. 2006;105:290-298. [PMID: 16618609 DOI: 10.1016/s0929-6646(09)60120-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
32 Blom K, Rubin J, Halfvarson J, Törkvist L, Rönnblom A, Sangfelt P, Lördal M, Jönsson UB, Sjöqvist U, Håkansson LD, Venge P, Carlson M. Eosinophil associated genes in the inflammatory bowel disease 4 region: Correlation to inflammatory bowel disease revealed. World J Gastroenterol 2012; 18(44): 6409-6419 [PMID: 23197886 DOI: 10.3748/wjg.v18.i44.6409] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
33 Mähler M, Bristol IJ, Leiter EH, Workman AE, Birkenmeier EH, Elson CO, Sundberg JP. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol 1998;274:G544-51. [PMID: 9530156 DOI: 10.1152/ajpgi.1998.274.3.G544] [Cited by in Crossref: 58] [Cited by in F6Publishing: 141] [Article Influence: 2.4] [Reference Citation Analysis]
34 Shrier I, Szilagyi A, Correa JA. Impact of lactose containing foods and the genetics of lactase on diseases: an analytical review of population data. Nutr Cancer 2008;60:292-300. [PMID: 18444163 DOI: 10.1080/01635580701745301] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
35 Sieper J, Rudwaleit M, Khan MA, Braun J. Concepts and epidemiology of spondyloarthritis. Best Pract Res Clin Rheumatol. 2006;20:401-417. [PMID: 16777573 DOI: 10.1016/j.berh.2006.02.001] [Cited by in Crossref: 140] [Cited by in F6Publishing: 120] [Article Influence: 8.8] [Reference Citation Analysis]
36 APDW2004 Chinese IBD Working Group. Retrospective analysis of 515 cases of Crohn's disease hospitalization in China: nationwide study from 1990 to 2003. J Gastroenterol Hepatol. 2006;21:1009-1015. [PMID: 16724987 DOI: 10.1111/j.1440-1746.2006.04140.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 2.7] [Reference Citation Analysis]
37 Elson CO, Sartor RB, Targan SR, Sandborn WJ. Challenges in IBD Research: updating the scientific agendas. Inflamm Bowel Dis. 2003;9:137-153. [PMID: 12792219 DOI: 10.1097/00054725-200305000-00001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
38 Farrokhyar F, Swarbrick ET, Irvine EJ. A critical review of epidemiological studies in inflammatory bowel disease. Scand J Gastroenterol 2001;36:2-15. [PMID: 11218235 DOI: 10.1080/00365520150218002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
39 Palli D, Trallori G, Saieva C, Tarantino O, Edili E, D'Albasio G, Pacini F, Masala G. General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study. Gut 1998;42:175-9. [PMID: 9536940 DOI: 10.1136/gut.42.2.175] [Cited by in Crossref: 86] [Cited by in F6Publishing: 85] [Article Influence: 3.6] [Reference Citation Analysis]
40 Evans PE, Pardi DS. Inflammatory bowel disease in the elderly. Aging Health 2007;3:77-84. [DOI: 10.2217/1745509x.3.1.77] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
41 Höie O, Schouten LJ, Wolters FL, Solberg IC, Riis L, Mouzas IA, Politi P, Odes S, Langholz E, Vatn M, Stockbrügger RW, Moum B; European Collaborative Study Group of Inflammatory Bowel Disease (EC-IBD). Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis. Gut 2007;56:497-503. [PMID: 17028127 DOI: 10.1136/gut.2006.101519] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 3.7] [Reference Citation Analysis]
42 Juillerat P, Pittet V, Bulliard J, Guessous I, Antonino AT, Mottet C, Felley C, Vader J, Michetti P. Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study. Journal of Crohn's and Colitis 2008;2:131-41. [DOI: 10.1016/j.crohns.2007.10.006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
43 Zhong XS, Winston JH, Luo X, Kline KT, Nayeem SZ, Cong Y, Savidge TC, Dashwood RH, Powell DW, Li Q. Neonatal Colonic Inflammation Epigenetically Aggravates Epithelial Inflammatory Responses to Injury in Adult Life. Cell Mol Gastroenterol Hepatol 2018;6:65-78. [PMID: 29928672 DOI: 10.1016/j.jcmgh.2018.02.014] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
44 Trinh C, Prabhakar K. Diarrheal diseases in the elderly. Clin Geriatr Med 2007;23:833-56, vii. [PMID: 17923341 DOI: 10.1016/j.cger.2007.06.005] [Cited by in Crossref: 36] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
45 Pardi DS, Loftus EV, Camilleri M. Treatment of Inflammatory Bowel Disease in the Elderly: An Update. Drugs & Aging 2002;19:355-63. [DOI: 10.2165/00002512-200219050-00004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
46 Brande JMH, Peppelenbosch MP, Deventer SJH. Treating Crohn's Disease by Inducing T Lymphocyte Apoptosis. Annals of the New York Academy of Sciences 2002;973:166-80. [DOI: 10.1111/j.1749-6632.2002.tb04628.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
47 Appleyard CB, Hernández G, Rios-Bedoya CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis. 2004;10:106-111. [PMID: 15168809 DOI: 10.1097/00054725-200403000-00007] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 3.3] [Reference Citation Analysis]
48 Zhang W, Yang AL, Liao J, Li H, Dong H, Chung YT, Bai H, Matkowskyj KA, Hammock BD, Yang GY. Soluble epoxide hydrolase gene deficiency or inhibition attenuates chronic active inflammatory bowel disease in IL-10(-/-) mice. Dig Dis Sci. 2012;57:2580-2591. [PMID: 22588244 DOI: 10.1007/s10620-012-2217-1] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
49 Jeon YD, Bang KS, Shin MK, Lee JH, Chang YN, Jin JS. Regulatory effects of glycyrrhizae radix extract on DSS-induced ulcerative colitis. BMC Complement Altern Med 2016;16:459. [PMID: 27846836 DOI: 10.1186/s12906-016-1390-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
50 Salih A, Widbom L, Hultdin J, Karling P. Smoking is associated with risk for developing inflammatory bowel disease including late onset ulcerative colitis: a prospective study. Scand J Gastroenterol. 2018;53:173-178. [PMID: 29262738 DOI: 10.1080/00365521.2017.1418904] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
51 Hait E, Bousvaros A, Grand R. Pediatric inflammatory bowel disease: what children can teach adults. Inflamm Bowel Dis. 2005;11:519-527. [PMID: 15905698 DOI: 10.1097/01.mib.0000166932.66853.fd] [Cited by in Crossref: 32] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
52 Taylor KD, Rotter JI, Yang H. Genetics of inflammatory bowel disease. In: Targan SR, Shanahan F, Karp LC, editors. Inflammatory Bowel Disease: From Bench to Bedside. Dordrecht: Springer Netherlands; 2003. pp. 21-65. [DOI: 10.1007/978-1-4020-3477-0_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
53 Luces C, Bodger K. Economic burden of inflammatory bowel disease: a UK perspective. Expert Rev Pharmacoecon Outcomes Res. 2006;6:471-482. [PMID: 20528516 DOI: 10.1586/14737167.6.4.471] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
54 Timmer A, Breuer-Katschinski B, Goebell H. Time trends in the incidence and disease location of Crohn's disease 1980-1995: a prospective analysis in an urban population in Germany. Inflamm Bowel Dis 1999;5:79-84. [PMID: 10338375 DOI: 10.1097/00054725-199905000-00002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.3] [Reference Citation Analysis]
55 Yang H, Taylor KD, Rotter JI. Inflammatory bowel disease. I. Genetic epidemiology. Mol Genet Metab 2001;74:1-21. [PMID: 11592800 DOI: 10.1006/mgme.2001.3199] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
56 Farrokhyar F, Swarbrick ET, Grace RH, Hellier MD, Gent AE, Irvine EJ. Low mortality in ulcerative colitis and Crohn's disease in three regional centers in England. Am J Gastroenterol. 2001;96:501-507. [PMID: 11232697 DOI: 10.1111/j.1572-0241.2001.03466.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 2.0] [Reference Citation Analysis]
57 Boonen A, Dagnelie PC, Feleus A, Hesselink MA, Muris JW, Stockbrügger RW, Russel MG. The impact of inflammatory bowel disease on labor force participation: results of a population sampled case-control study. Inflamm Bowel Dis. 2002;8:382-389. [PMID: 12454613 DOI: 10.1097/00054725-200211000-00002] [Cited by in Crossref: 89] [Cited by in F6Publishing: 79] [Article Influence: 4.7] [Reference Citation Analysis]
58 Orholm M, Fonager K, Sørensen HT. Risk of ulcerative colitis and Crohn’s disease among offspring of patients with chronic inflammatory bowel disease. Am J Gastroenterol. 1999;94:3236-3238. [PMID: 10566721 DOI: 10.1111/j.1572-0241.1999.01526.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 72] [Article Influence: 3.7] [Reference Citation Analysis]
59 Sinčić BM, Vucelić B, Peršić M, Brnčić N, Eržen DJ, Radaković B, Mićović V, Štimac D. Incidence of inflammatory bowel disease in Primorsko-goranska County, Croatia, 2000–2004: A prospective population-based study. Scandinavian Journal of Gastroenterology 2009;41:437-44. [DOI: 10.1080/00365520500320094] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 5.0] [Reference Citation Analysis]
60 Oliva-Hemker M, Fiocchi C. Etiopathogenesis of inflammatory bowel disease: the importance of the pediatric perspective. Inflamm Bowel Dis 2002;8:112-28. [PMID: 11854610 DOI: 10.1097/00054725-200203000-00008] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 3.0] [Reference Citation Analysis]
61 Ott C, Obermeier F, Thieler S, Kemptner D, Bauer A, Schölmerich J, Rogler G, Timmer A. The incidence of inflammatory bowel disease in a rural region of Southern Germany: a prospective population-based study. Eur J Gastroenterol Hepatol. 2008;20:917-923. [PMID: 18794607 DOI: 10.1097/meg.0b013e3282f97b33] [Cited by in Crossref: 64] [Cited by in F6Publishing: 15] [Article Influence: 4.6] [Reference Citation Analysis]
62 Cachia E, Calleja N, Aakeroy R, Degaetano J, Vassallo M. Incidence of inflammatory bowel disease in Malta between 1993 and 2005: a retrospective study. Inflamm Bowel Dis. 2008;14:550-553. [PMID: 18183599 DOI: 10.1002/ibd.20321] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
63 Zhu L, Gu P, Shen H. Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats. Int Immunopharmacol 2019;68:242-51. [PMID: 30743078 DOI: 10.1016/j.intimp.2018.12.036] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 16.3] [Reference Citation Analysis]
64 Russel M. Changes in the incidence of inflammatory bowel disease: what does it mean? European Journal of Internal Medicine 2000;11:191-6. [DOI: 10.1016/s0953-6205(00)00090-x] [Cited by in Crossref: 59] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
65 El-Tawil AM. Smoking and inflammatory bowel diseases: what in smoking alters the course? Int J Colorectal Dis. 2010;25:671-680. [PMID: 20333390 DOI: 10.1007/s00384-010-0925-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
66 Harrison CA, Laubitz D, Midura-Kiela MT, Jamwal DR, Besselsen DG, Ghishan FK, Kiela PR. Sexual Dimorphism in the Response to Broad-spectrum Antibiotics During T Cell-mediated Colitis. J Crohns Colitis 2019;13:115-26. [PMID: 30252029 DOI: 10.1093/ecco-jcc/jjy144] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
67 Reynisdottir I, Gudbjartsson DF, Johannsson JH, Manolescu I, Kristjansson K, Stefansson K, Gulcher J, Bjornsson S. A genetic contribution to inflammatory bowel disease in Iceland: a genealogic approach. Clin Gastroenterol Hepatol 2004;2:806-12. [PMID: 15354281 DOI: 10.1016/s1542-3565(04)00351-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
68 Buller H, Chin S, Kirschner B, Kohn J, Markowitz J, Moore D, Murch S, Taminiau J. Inflammatory Bowel Disease in Children and Adolescents: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition: . Journal of Pediatric Gastroenterology and Nutrition 2002;35:S151-8. [DOI: 10.1097/00005176-200208002-00013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
69 Nimmons D, Limdi JK. Elderly patients and inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2016; 7(1): 51-65 [PMID: 26855812 DOI: 10.4292/wjgpt.v7.i1.51] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
70 de Mesquita MB, Civitelli F, Levine A. Epidemiology, genes and inflammatory bowel diseases in childhood. Dig Liver Dis 2008;40:3-11. [PMID: 17997369 DOI: 10.1016/j.dld.2007.07.165] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
71 Ravikumara M, Sandhu BK. Epidemiology of inflammatory bowel diseases in childhood. Indian J Pediatr 2006;73:717-21. [PMID: 16936368 DOI: 10.1007/BF02898451] [Cited by in Crossref: 17] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
72 Lauer K. Environmental risk factors in multiple sclerosis. Expert Review of Neurotherapeutics 2014;10:421-40. [DOI: 10.1586/ern.10.7] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 6.1] [Reference Citation Analysis]
73 Salupere R. Inflammatory bowel disease in Estonia: a prospective epidemiologic study 1993-1998. World J Gastroenterol 2001; 7(3): 387-388 [PMID: 11819795 DOI: 10.3748/wjg.v7.i3.387] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
74 Sentongo TA, Semeao EJ, Piccoli DA, Stallings VA, Zemel BS. Growth, body composition, and nutritional status in children and adolescents with Crohn's disease. J Pediatr Gastroenterol Nutr 2000;31:33-40. [PMID: 10896068 DOI: 10.1097/00005176-200007000-00009] [Cited by in Crossref: 108] [Cited by in F6Publishing: 87] [Article Influence: 5.1] [Reference Citation Analysis]
75 Sicilia B, López Miguel C, Arribas F, López Zaborras J, Sierra E, Gomollón F. Environmental risk factors and Crohn's disease: a population-based, case-control study in Spain. Dig Liver Dis. 2001;33:762-767. [PMID: 11838611 DOI: 10.1016/s1590-8658(01)80693-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
76 Bernstein CN, Blanchard JF. Viruses and inflammatory bowel disease: is there evidence for a causal association? Inflamm Bowel Dis 2000;6:34-9. [PMID: 10701147 DOI: 10.1097/00054725-200002000-00005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
77 van Deventer SJ. Anti-TNF antibody treatment of Crohn's disease. Ann Rheum Dis 1999;58 Suppl 1:I114-20. [PMID: 10577987 DOI: 10.1136/ard.58.2008.i114] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
78 Montalto M, Curigliano V, Santoro L, Armuzzi A, Cammarota G, Covino M, Mentella MC, Ancarani F, Manna R, Gasbarrini A, Gasbarrini G. Fecal calprotectin in first-degree relatives of patients with ulcerative colitis. Am J Gastroenterol 2007;102:132-6. [PMID: 17100982 DOI: 10.1111/j.1572-0241.2006.00884.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
79 Xia B, JBA C, SGM M, AS P. Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies. World J Gastroenterol 1998; 4(5): 446-458 [PMID: 11819343 DOI: 10.3748/wjg.v4.i5.446] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 19] [Article Influence: 0.7] [Reference Citation Analysis]
80 Pinsk V, Lemberg DA, Grewal K, Barker CC, Schreiber RA, Jacobson K. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol 2007;102:1077-83. [PMID: 17378907 DOI: 10.1111/j.1572-0241.2007.01124.x] [Cited by in Crossref: 114] [Cited by in F6Publishing: 106] [Article Influence: 7.6] [Reference Citation Analysis]
81 Birnbaum G, Kotilinek L, Miller SD, Raine CS, Gao YL, Lehmann PV, Gupta RS. Heat shock proteins and experimental autoimmune encephalomyelitis. II: environmental infection and extra-neuraxial inflammation alter the course of chronic relapsing encephalomyelitis. J Neuroimmunol 1998;90:149-61. [PMID: 9817443 DOI: 10.1016/s0165-5728(98)00141-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
82 Mamula P, Markowitz JE, Baldassano RN. Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol Clin North Am. 2003;32:967-95, viii. [PMID: 14562584 DOI: 10.1016/s0889-8553(03)00046-3] [Cited by in Crossref: 130] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
83 Katz S, Pardi DS. Inflammatory bowel disease of the elderly: frequently asked questions (FAQs). Am J Gastroenterol. 2011;106:1889-1897. [PMID: 21862997 DOI: 10.1038/ajg.2011.271] [Cited by in Crossref: 69] [Cited by in F6Publishing: 64] [Article Influence: 6.3] [Reference Citation Analysis]
84 Nishikawa M, Oshitani N, Matsumoto T, Nishigami T, Arakawa T, Inoue M. Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis. Br J Cancer. 2005;93:331-337. [PMID: 15956973 DOI: 10.1038/sj.bjc.6602664] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 2.7] [Reference Citation Analysis]
85 Tzanakis NE, Tsiligianni IG, Siafakas NM. Pulmonary involvement and allergic disorders in inflammatory bowel disease. World J Gastroenterol 2010; 16(3): 299-305 [PMID: 20082474 DOI: 10.3748/wjg.v16.i3.299] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
86 Welton ML, Varma MG, Amerhauser A. Colon, Rectum, and Anus. In: Norton JA, Bollinger RR, Chang AE, Lowry SF, Mulvihill SJ, Pass HI, Thompson RW, editors. Surgery. Berlin: Springer Berlin Heidelberg; 2001. pp. 667-762. [DOI: 10.1007/978-3-642-57282-1_33] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
87 Bernstein CN, Nabalamba A. Hospitalization-based major comorbidity of inflammatory bowel disease in Canada. Can J Gastroenterol 2007;21:507-11. [PMID: 17703250 DOI: 10.1155/2007/924257] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
88 Söderholm JD, Olaison G, Lindberg E, Hannestad U, Vindels A, Tysk C, Järnerot G, Sjödahl R. Different intestinal permeability patterns in relatives and spouses of patients with Crohn's disease: an inherited defect in mucosal defence? Gut 1999;44:96-100. [PMID: 9862833 DOI: 10.1136/gut.44.1.96] [Cited by in Crossref: 131] [Cited by in F6Publishing: 132] [Article Influence: 5.7] [Reference Citation Analysis]
89 Jonkers D, Stockbrügger R. Probiotics and Inflammatory Bowel Disease. J R Soc Med 2003;96:167-71. [DOI: 10.1177/014107680309600403] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 3.8] [Reference Citation Analysis]
90 Malaty HM, Fan X, Opekun AR, Thibodeaux C, Ferry GD. Rising Incidence of Inflammatory Bowel Disease Among Children: A 12-year Study. Journal of Pediatric Gastroenterology & Nutrition 2010;50:27-31. [DOI: 10.1097/mpg.0b013e3181b99baa] [Cited by in Crossref: 145] [Cited by in F6Publishing: 53] [Article Influence: 12.1] [Reference Citation Analysis]
91 Karlinger K, Györke T, Makö E, Mester A, Tarján Z. The epidemiology and the pathogenesis of inflammatory bowel disease. Eur J Radiol. 2000;35:154-167. [PMID: 11000558 DOI: 10.1016/s0720-048x(00)00238-2] [Cited by in Crossref: 174] [Cited by in F6Publishing: 64] [Article Influence: 7.9] [Reference Citation Analysis]
92 Juneja M, Baidoo L, Schwartz MB, Barrie A 3rd, Regueiro M, Dunn M, Binion DG. Geriatric inflammatory bowel disease: phenotypic presentation, treatment patterns, nutritional status, outcomes, and comorbidity. Dig Dis Sci 2012;57:2408-15. [PMID: 22359191 DOI: 10.1007/s10620-012-2083-x] [Cited by in Crossref: 94] [Cited by in F6Publishing: 84] [Article Influence: 9.4] [Reference Citation Analysis]
93 Gearry RB, Richardson A, Frampton CM, Collett JA, Burt MJ, Chapman BA, Barclay ML. High incidence of Crohn’s disease in Canterbury, New Zealand: results of an epidemiologic study. Inflamm Bowel Dis. 2006;12:936-943. [PMID: 17012964 DOI: 10.1097/01.mib.0000231572.88806.b9] [Cited by in Crossref: 185] [Cited by in F6Publishing: 179] [Article Influence: 12.3] [Reference Citation Analysis]
94 Zijlstra FJ, van Meeteren ME, Garrelds IM, Meijssen MA. Effect of pharmacologically induced smooth muscle activation on permeability in murine colitis. Mediators Inflamm 2003;12:21-7. [PMID: 12745545 DOI: 10.1080/0962935031000096944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
95 Palli D, Trallori G, Bagnoli S, Saieva C, Tarantino O, Ceroti M, D'albasio G, Pacini F, Amorosi A, Masala G. Hodgkin's disease risk is increased in patients with ulcerative colitis. Gastroenterology 2000;119:647-53. [DOI: 10.1053/gast.2000.16487] [Cited by in Crossref: 92] [Cited by in F6Publishing: 87] [Article Influence: 4.2] [Reference Citation Analysis]
96 Ishige T, Tomomasa T, Takebayashi T, Asakura K, Watanabe M, Suzuki T, Miyazawa R, Arakawa H. Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in Japan. J Gastroenterol 2010;45:911-7. [DOI: 10.1007/s00535-010-0223-7] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 5.6] [Reference Citation Analysis]
97 Kim SJ, Kim YG, Kim DS, Jeon YD, Kim MC, Kim HL, Kim SY, Jang HJ, Lee BC, Hong SH, Um JY. Oldenlandia diffusa Ameliorates Dextran Sulphate Sodium-Induced Colitis Through Inhibition of NF-κB Activation. Am J Chin Med 2011;39:957-69. [PMID: 21905285 DOI: 10.1142/S0192415X11009330] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
98 Delcò F, Sonnenberg A. Commonalities in the time trends of Crohn's disease and ulcerative colitis. Am J Gastroenterol 1999;94:2171-6. [PMID: 10445545 DOI: 10.1111/j.1572-0241.1999.01290.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.3] [Reference Citation Analysis]